Trump Selects Heidi Overton to Lead FDA

Overton steps into a role left unsettled since May, when Marty Makary resigned following internal friction with administration health advisors. Since then, Kyle Diamantas has managed the agency in an acting capacity. The transition marks a pivotal shift for the FDA as it navigates ongoing policy disagreements and administrative pressure. Neither the White House nor the agency has released a formal statement regarding the appointment, which follows Overton’s tenure within the administration’s domestic policy framework.